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Background
Mitral regurgitation (MR) is usually well tolerated, and even those with severe asymptomatic regurgitation can survive many years, though around a third develop indications for surgery by 5 years. 1 Mitral valve repair or replacement is indicated once symptoms or adverse cardiac features develop 2 (e.g. left ventricular dysfunction/excess dilation), as prognosis is significantly reduced without treatment. [3] [4] [5] However, even with surgery prognosis may be reduced at this stage, and early surgery for severe regurgitation has been advocated. 6, 7 The latest guidelines now consider this to be 'reasonable' (class 2a indication) if severe MR is present, the chance of mitral repair is high (>95%), and the surgery is carried out in a centre of excellence with a very low mortality, or other conditions exist (pulmonary hypertension or new onset atrial fibrillation). 2 This 'aggressive' approach has to be balanced against the favourable natural history of untreated mitral regurgitation without symptoms or other adverse features, and the risks of early surgery, particularly in an elderly population in whom the risks of surgery are higher. There is therefore considerable debate between those who advocate a 'watchful waiting' strategy 1 versus those who favour early surgery. 8, 9 Determining the correct clinical approach is hindered by the lack of any controlled trial of early surgery, and the difficulty in identifying which patients should be offered this while asymptomatic. Advance identification of those patients likely to progress to symptoms or other indications for surgery in the near future could highlight the group most likely to benefit, and facilitate early surgery before prognosis was reduced.
Quantifying the MR in those with significant regurgitation (rather than qualitative grading) might be one method to identify such patients. This can be achieved with echocardiography (Echo), 10 though Echo quantitation is primarily used to aid grading into mild, moderate and severe regurgitation, 10 rather than identifying patients for surgery. One important mortality, or other conditions exist (pulmonary hypertension or new onset atrial f f fib ib ibri ri rill ll llat at atio io ion) n) n). . . 2 2 2 This 'aggressive' approach has to be balanced against the favourable natural history of untreated u mitr ral al al r r reg eg egur ur urgi gi g tati ti ion on n without symptoms or other a a adv dv dve erse features, and the he he risks of early surgery, p p part t ticularly in an an an e eld d der er erly y y p p pop op opul ul ulat at atio io ion n n in in in w who om m m the ris sks s of of of s sur ur urge ge gery ry y a a are re h h hig i igh her. . . Th Th Ther er ere e e is i i t t th h here re refo fo fore re re co o ons ns nsid id i erable e e d d deb b bat t te be e etw w ween n n th h hos o e e e w w who ho o a adv v voc oc ocate a 'w w wat at atc chfu fu ful l wa wa waiti i ing' g g s s str rateg eg egy y y 1 ver r rsu su sus t tho o ose wh w who fa fa favo o vour r ur e e ear ar arly l ly s s sur r urge ge gery r ry. 8, 8, 8, 9 9 D D Det et eter er ermi mi mini ni ning ng ng t t the he he c c cor or orre re rect ct ct c c cli li lini ni nica ca cal l l ap ap appr pr proa oa oach ch ch i i is s s hi hi hind nd nder er ered ed ed b b by th th the e e la la lack ck ck o o of f f an an any study has shown an association of quantitative Echo MR grading with mortality in medicallytreated patients, 11 but this did not address the identification of patients for surgery.
Cardiovascular magnetic resonance (CMR) is able to quantify mitral regurgitation with high accuracy and reproducibility, using a combination of left ventricular (LV) volumetric measurement and aortic flow quantification with phase contrast velocity mapping. 12 Given that left ventricular (LV) volumes and function are also important for MR assessment, and that CMR is considered the 'reference-standard' method for measuring these, 13 it would appear to be an optimal technique for the assessment of mitral regurgitation. We previously used this technique in patients with aortic regurgitation, and demonstrated a strong association of the quantification of regurgitation with outcome. 14 We therefore sought to examine whether a similar approach using CMR quantitation of mitral regurgitation and LV indices might be able to predict which asymptomatic patients with significant (moderate or severe) MR were likely to progress to symptoms or other established indications for surgery. We also aimed to compare the CMR quantitation of mitral regurgitation and LV volume/function indices for their relative predictive ability.
Methods
Subjects and follow up
Patients at least 18 years of age were recruited from four high-volume CMR centres in Oxford, Leeds, London (UK) and Auckland (New Zealand). All asymptomatic patients with moderate or severe chronic organic mitral regurgitation on echocardiography were eligible for inclusion and underwent baseline CMR scanning. Exclusion criteria included the presence of 'functional' mitral regurgitation (secondary to annular dilation or LV dysfunction), other significant valve of regurgitation with outcome. 14 We therefore sought to examine whether a simila la ar r r ap ap appr pr proa oa oach ch ch using CMR quantitation of mitral regurgitation and LV indices might be able to predict which asym m mpt pt ptom om omat at atic ic ic pat at atie ie ients with significant (moderate te te o o or r severe) MR were l l lik ik ikely to progress to y y ym mp m toms or ot t th h her r es es st ta t bl bl blis is ishe he hed d d i in indi di dic c cati ti tion ns fo fo for surg ge e ery. W W We e al al also so so a a aim m med ed ed t t to comp mp mpa ar are e e th th the CM CM CMR R R qu u uan an anti t t tation n n o o of m mi m t tr t al r r re eg egurgi gi gita a ati ti t on n n a a and d d L L LV vo vo volum me/ / /fun n nc c ction on n i i ind nd n i i ice e es f f for r r th heir ir ir r r rel e e ativ v ve e e pred ed dictive v ve ab ab abil il ilit it ity.
disease and clinical and/or angiographic evidence of coronary disease.
Subjects were followed for up to 8 years. Those who remained asymptomatic and under conservative management were designated the 'conservative' group, while those who developed symptoms or other established indications for surgery 2 were designated the 'crossover' group, with the decision for surgery taken as the point of censoring. Subjects were only included in the crossover group if the surgery was indicated on established criteria, 2 which do not include CMR assessment. Any subjects undergoing mitral valve replacement/repair for indications outside these criteria (including mitral repair performed for asymptomatic severe MR without other indications of adverse prognosis) remained in the conservative group but were censored at the time of surgery. In addition, a minimum period of one month was required between the CMR scan and the decision for surgery, to avoid the potential bias of patients having a predesignated CMR scan 'en-route' to surgery. All clinical decisions were taken by the treating physician. In
Oxford, patients participated in a research study, and clinical decisions were made without knowledge of the CMR data. In the other three centres, study patients were identified from the clinical CMR databases (having been initially diagnosed with Echo) and clinicians had access to the CMR data, although as indicated above, there are no CMR-based criteria for surgery.
A third group was also included to compare CMR parameters with both the conservative and crossover groups. This group included patients who had already developed established indications for surgery 2 and were scheduled for mitral valve repair/replacement (the 'surgical' group). They underwent identical CMR scans to the other groups.
The research study was approved by the Oxfordshire Central Research Ethics Committee (Project code C02.020) and the Waitemata District Health Board "Knowledge Centre" in New
Zealand (Project number RM0980711302); all research subjects gave written informed consent.
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CMR scanning
All scans were performed on clinical 1. Aortic forward flow was quantified using through-plane phase-contrast velocity-mapping as previously described, 15, 16 with the image plane placed either just above the aortic valve at end-diastole or at the sinotubular junction ( Figure 1 ). If significant turbulence or aliasing was seen in the velocity image, the acquisition was repeated a few millimetres further from the valve, and/or with a higher velocity window. Free-breathing flow sequences were used in Oxford, while breath-hold flow sequences were used in the other three centres. Our previous work has shown that the choice of pulse sequence (free-breathing versus breath-hold) does not significantly affect the quantitative results. 14 In all centres, the potential for background flow offset errors was reduced 17 by ensuring flow sequences were acquired with the region of interest located at the o apex, from which left ventricular end-diastolic and end-systolic volumes (LVED ED EDV V V an an and d d
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Echocardiography
Transthoracic echocardiograms were acquired for clinical management a mean of 47.1 ±71.6
days from the baseline CMR scan, according to standard protocols. 18 The images for the prospectively followed subjects (conservative and crossover groups) were re-assessed by the researchers, blinded to CMR and outcome data, and determination of the grade of MR on echocardiography was made. This was based on multiple two-dimensional imaging parameters, as described in the American Society of Echocardiography guidelines. 10 These were both qualitative and semi-quantitative, and quantitative assessments were used wherever feasible (including assessment of effective regurgitant orifice area (EROA) by the proximal isovolumetric surface area method 19 ) if accurate measurements could be obtained.
Data assessment and statistical analysis
Receiver operating characteristic (ROC) analysis was used as the initial test to identify the imaging parameters with a reasonable ability (area under the curve [AUC] >0.75) to identify ets. Regurgitant fraction was also determined (regurgitant volume/LV stroke vol lum um ume e e x x x 10 10 100% 0% 0%). ) ) d
Echocardiography
Tran n nst st stho ho hora ra raci ci cic c c ec c cho ho hocardiograms were acquired fo fo or r r cl cl c inical management t t a a a mean of 47. optimal threshold for sensitivity and specificity was determined using the Youden index.
Stepwise Cox proportional-hazards regression analysis was also performed on these parameters to determine which were independent predictors.
Kaplan-Meier survival curves are more appropriate for assessing the occurrence of events over time, and these were generated for parameters with an ROC AUC >0.70 to identify the strongest predictors. There are however no existing CMR thresholds for regurgitation severity to 
Association with the need for surgery
The ROC analyses identified several baseline CMR parameters associated with the development of indications for surgery (table 1) . Quantitative measures of MR (mitral regurgitant volume and fraction) both had a high area under the curve (AUC), with good sensitivity and specificity.
CMR LV volumetric indices also showed good discriminatory ability. LV mass showed some predictive power, but this parameter is closely related to LVEDV, and the similar mass:volume ratios in all groups ( 
56%) %) %).
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Th Th he RO R R C an n nal a a ys s ses s s ide e ent t tified d d se se severa ra ral l l b b bas se s lin n ne CMR MR R pa a ara a ame e ete e ers s s a a ass s soc oc cia a ate ed w w with th th the e e d d deve elo o opm m men nt of of of i i ind nd ndic ic icat at atio io ions ns ns f f for or or s s sur r urge ge gery r ry ( ( (ta ta tabl bl ble e e 1) 1) 1). Qu Q Quan an anti ti tita ta tati ti tive e ve m m mea ea easu s sure re res s s of of of M M MR R R (m (m (mit it itra ra ral l l re re regu g gurg rg rgit it itan an ant t t vo o volu l lume me me a a and nd nd cut-off threshold for discrimination of the need for surgery was performed for regurgitant volume, regurgitant fraction and LVEDVindex. For regurgitant volume, cut-off levels between 30 and 65 ml were analysed using Cox proportional hazards, and the highest values of the Harrell's C and Somers' D statistics were associated with a cut-off threshold of 55 ml. For regurgitant fraction, cut-off levels between 20 and 50% were investigated, and the optimum cut off level was 40%. For LVEDVindex, cut-off levels between 80 and 130 ml/m 2 were investigated, and the optimum cut off level was 100 ml/m 2 . These thresholds were then used to separate sub-groups in the survival analyses.
CMR measures of regurgitation demonstrated substantial separation of groups over time.
Subjects with a regurgitant volume 55ml had a very high chance of remaining free of symptoms or surgery: 95% at the median time (1.6 years) and 91% at 5 years. This contrasted with 54% at 1.6 years and 21% at 5 years for patients with regurgitant volume >55ml (p<0.0001 by logrank, Figure 2a ). Similar differences in survival without surgery were seen for regurgitant fraction above and below 40%. Inclusion of an additional threshold at a regurgitant fraction of 50% however (dividing the cohort into 3 sub-groups of 40%, 41-50% and >50%) revealed a further separation in survival without surgery, and we have illustrated this incremental risk of surgery with increasing regurgitant fraction in figure 2b. There were no significant differences in survival curves amongst the participating centres (p=0.80 by logrank test).
LVEDV also showed a reasonable association with outcome over time, though slightly weaker than for measures of regurgitation (proportions surviving without surgery at the median of 1.6 years: 96% for LVEDVi <100ml/m 2 versus 71% for 100ml/m 2 ; p=0.0001), Figure 2c .
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Echocardiographic grading of MR performed less well in predicting subjects who progressed to surgery, despite the use of quantitative assessment to guide grading where feasible (n=53, 49% of the total). Many of those identified as severe MR on Echo had MR volumes on CMR <55ml, and remained asymptomatic (n=28). There was much less of a tendency to underestimate the MR with Echo (compared to CMR), with only 5 subjects with moderate MR on Echo and regurgitant volume >55ml by CMR. Overall, if the CMR threshold of a regurgitant volume >55ml is used to define severe MR, 33 subjects (30% of the total) were reclassified by CMR compared to echocardiographic grading. The prediction of events using only quantitative
Echo thresholds for severity (effective regurgitant orifice area above and below 0.40cm 2 ) showed only modest separation of survival curves (figure 2d), though numbers in this sub-group were smaller (n=53), and the difference in outcome was not statistically significant. Using Echoderived regurgitant volume >60ml as the threshold provided very similar results (data not shown).
Furthermore, in both moderate and severe echocardiographic MR sub-groups, there was similar separation of survival curves by CMR quantitation (Figure 3b ). 65 subjects had follow-up echocardiograms during the study period and these were also analysed in the same blinded fashion as the initial studies. Nearly all had similar findings to the first scan, with only one subject who progressed to surgery showing a change in the grade of MR by Echo (from moderate to severe), but this may not be surprising given the tendency for the initial Echo to overestimate the severity of MR, highlighted above.
Comparison with the surgical group
volume >55ml is used to define severe MR, 33 subjects (30% of the total) were re e ecl cl clas as assi si sifi fi fied indices to the crossover group, and both parameters were larger than in the conservative group.
There were no significant differences in ejection fraction, or RV parameters. Systolic blood pressure was lower in the surgical group compared to the conservative one.
Discussion
The association of mitral regurgitation quantitation with outcome
Quantifying mitral regurgitation with CMR showed a strong association with the future need for surgery over the subsequent 5 years, demonstrating the potential value of this approach. Patients already destined for surgery (the 'surgical' group) also had measures of mitral regurgitation that were similar to the 'crossover' group, suggesting that a similar threshold of regurgitation had been reached in the surgical group before symptoms occurred. These CMR parameters might thus be useful clinical predictors of the need for surgery. In addition to the potential for high quantitative indices of regurgitation to identify candidates for early surgery, subjects with lower amounts of MR (regurgitant volume 55ml or fraction 40%) had a very low chance of requiring surgery over the subsequent few years and could be followed up less frequently, with a favourable impact on healthcare resources. We identified the best single thresholds to predict the groups with different outcomes, but it is likely that there is an increasing risk with increasing values of the parameters, as the separation of the three groups for mitral regurgitant fraction illustrate (figure 2b). The thresholds identified in this study should be treated with caution
The association of mitral regurgitation quantitation with outcome
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The separation of the Kaplan-Meier event curves was slightly less pronounced than in our previous work in aortic regurgitation, 14 and this may be due to a number of factors. Mitral regurgitation is dependent on other factors (e.g. fluid balance, filling pressures, LV function), and the quantity of MR may vary more widely over a period of time than for aortic regurgitation.
Thus, a single measurement may show a weaker link with outcome. Secondly, the CMR technique for quantification is indirect and relies on both LV stroke volume measurement and aortic forward flow quantification, introducing more potential for error, which could also weaken the association with outcome. The threshold of regurgitant fraction that best differentiated the groups likely to progress to surgery was also higher for mitral regurgitation (40%, versus 33% for aortic regurgitation), which may reflect a greater ability of the left ventricle to cope with mitral regurgitation before the development of symptoms, particularly as the additional volume load is ejected into the low pressure left atrium rather than the high pressure aorta. Our findings also suggest that the thresholds for identifying severe mitral and aortic regurgitation should differ.
There are currently no CMR-specific thresholds, but the AHA-ACC echocardiographic thresholds indicating severe regurgitant volume (60ml) and fraction (50%) are the same for both valve lesions. 2 Interestingly, these values are close to the thresholds for the best identification of future symptoms in the present study, both for mitral regurgitant volume (55ml) and for fraction, and the quantity of MR may vary more widely over a period of time than for aorti ti tic c c re re regu gu gurg rg rgit it itat at atio io ion
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especially with the higher rate of progression to symptoms with a regurgitant fraction >50% (Figure 2b ). For aortic regurgitation however, the AHA-ACC thresholds are somewhat higher than the optimal thresholds identified in our previous study (regurgitant fraction 33% or volume 42ml), which may suggest that different thresholds for each valve lesion and/or CMR-specific thresholds should be considered.
Comparison with LV and RV volumetric indices
The highly accurate measurements of LVEDV by CMR showed a reasonable association with survival without surgery over time, but regurgitation quantification showed a better separation of survival curves. Further, combining LVEDV and regurgitant volume sub-groups did not improve survival curves over regurgitant volume alone, and subjects with low regurgitant volumes (figure 3a) had similarly low rates of surgery irrespective of the LVEDVi. This suggests that LVEDV may partly be a function of the quantity of regurgitation (supported by the strong association of LVEDV with mitral regurgitant volume). 20 This would be logical given that regurgitation is the physiological stimulus for LV dilation in this patient group, though is not conclusively proven with our data, and the several subjects with higher LVEDVi but low regurgitant volume (figure 3a) suggests there are other factors influencing LVEDV. Despite its longstanding use in previous guidelines, LVESV did not have a particularly strong association with outcome. However, LV volumes and function are important in overall assessment and readily available from a standard CMR scan. LV mass showed an apparent association with progression to surgery but this parameter is closely related to LV volume and it was not an independent predictor. Other studies have not shown any predictive power of wall thickness 21 and LV mass:volume ratios were similar for all three groups in our study, suggesting that there is no excess increase in mass over that required for the chamber volume increase, and that the apparent association of LV mass with urvival curves over regurgitant volume alone, and subjects with low regurgitant vo vo volu lu lume me mes s s (f (f (fig ig igu ur u e 3a) had similarly low rates of surgery irrespective of the LVEDVi. This suggests that LVEDV may y y pa pa part rt rtly ly ly b b be e e a fu fu fun nc n tion of the quantity of regurg rg rgit it itat a a ion (supported by th th the e strong association of L L LVE ED E V with h m m mi i itr ral l re re regu gu gurg rg rgit it i an an ant t t vo vo volu lu lum m me) ). 20 0 0 T T Th hi h s wo wo ould d d be be be l l log og ogic cal a a g g gi iv ive e en n n t that r r reg eg egur ur urgi gi gita t t ti ti tion on on i i is s s th th the e e ph h hys ys ysio i i logica ca al l l stim m imulus s s f f for L L LV V V di d d la ati ti tion on on in n n th hi i is p p patien n nt g g gro o oup up p, , , th h hou ou ough h h i i is s n n not t co on onc c clusiv v ve e ely pr pr proven n n t wi i with th th o o our r ur d d dat at ata a a, a a and nd nd t t the he he s s sev e ever er eral al al s s sub b ubje je ject ct cts s s wi i with th th hi hi high gh gher er er L L LVE VE VEDV DV DVi i i bu b but t t lo lo low re re regu g gurg rg rgit it itan an ant t t vo o volu l lume me me ( ( (fi fi figu g gure re re outcome is likely to be confounded by its close relation to LV volume. The lack of any notable association of RV parameters (including volumes and ejection fraction) with outcome, together with the similar (normal) values in all three groups, suggests that RV dilation or dysfunction may be a late and uncommon occurrence, and may only occur secondary to LV dysfunction and the resulting pulmonary hypertension.
Systemic blood pressure
Systemic blood pressure was lower in the crossover and surgical groups, which may reflect the larger mitral regurgitant volumes (and reduced aortic forward flow) in these groups. It is possible the lower blood pressure was a confounding factor that might have increased the chance of developing indications for surgery, although no previous study has suggested a causal link between blood pressure and the need for surgery in mitral regurgitation. Further, systolic blood pressure was not a good discriminator on the initial receiver operating characteristic analysis (area under the curve = 0.64).
Comparison between echocardiography and CMR
In our study, transthoracic echocardiographic grading showed a more modest ability to discriminate between subjects progressing to surgery and those remaining asymptomatic, with significant spread of the Echo grades across the conservative and crossover groups, and a tendency for Echo to overestimate the degree of regurgitation when compared to CMR. We were however only able to apply quantitative Echo grading in ~50% of subjects, and had this been possible in all subjects, it may have improved the results for Echo. Previous studies also suggest only moderate agreement between CMR and Echo, [22] [23] [24] and limited reproducibility for quantitative Echo grading. 25, 26 This may be in part due to assumptions in the PISA technique (the commonest Echo quantitative method). The peak PISA measurement assumes a static developing indications for surgery, although no previous study has suggested a cau au ausa sa sal l l li li link nk nk between blood pressure and the need for surgery in mitral regurgitation. Further, systolic blood pres ssu su sure re re w w was as as not t t a a a good discriminator on the ini iti ti tia a al l l receiver operating c c cha h h racteristic analysis a a are e ea under th he e c cu c r rve e e = 0. 0. 0.64 64 64). ). ).
Co Co Comp mp mparison on on bet t tw we w en n n e e echoc oc car ar rdi diog og ogra ra aph ph phy y an an and d CM M MR n n n o o our r ur s s stu t tudy d dy, tr tr tran an anst st stho ho hora ra raci ci cic c c ec ec echo ho hoca ca card rd rdio io iogr gr grap ap aphi hi hic c c gr gr grad ad adin in ing g g sh sh show o owed ed ed a a a mo mo more re re m m mod od odes es est t t ab ab abil il ilit it ity to to to degree of regurgitation throughout systole, and this may not hold true for some subjects, particularly those with mitral prolapse -this could result in over-estimation of the degree of regurgitation. 27 Other aspects may also reduce the accuracy of PISA Echo quantitation, including irregular regurgitant jets (eccentrically-directed, fan-shaped/crescentic, or multiple), nonhemispheric geometry of the PISA shell and difficulty in identifying the regurgitant orifice.
26-28
Although it is acknowledged there is no ideal gold standard for comparison, CMR quantitation of regurgitation has shown better intra-and inter-observer variability, 29 and good agreement with in-vitro models 23 and post-surgical LV remodelling.
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Previous studies of outcome in mitral regurgitation
Earlier studies examined outcomes after mitral valve surgery, demonstrating poorer 10 year survival following the development of symptoms 3 or LV impairment, 4 and poorer post-operative LV function once pre-operative end-systolic dimension exceeded 5.0cm (an indicator of both dilation and reduced function). 30 These studies informed the current guideline indications for surgery in mitral regurgitation 2 and, like the present study, highlight the value of identifying patients prior to symptoms or significant LV dilation/dysfunction. Chronic mitral regurgitation also increases left atrial size and can raise pulmonary pressure, resulting in RV dysfunction. Both increased atrial size 21, 31 and reduced RV or biventricular function 32 have been shown to predict medium and long term survival following mitral surgery. Reduced RV function on exercise has also shown some association with symptoms and outcome. 33, 34 The lack of an association of RV function with future progression to surgery in our study might indicate that this is a late sign in decompensated mitral regurgitation, which is usually absent in an asymptomatic population such as ours -several of the previous studies involved patients with symptoms. We also did not assess RV function during exercise, and it is unclear whether this might explain some of the difference.
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Clinical utility
Accurate assessment of the severity of mitral regurgitation and LV volumes/function is crucial in clinical decision making 7 and CMR would already seem well suited for this. The additional ability to predict the onset of symptoms or other indications for surgery just prior to their occurrence would be clinically important, and might identify a suitable cohort for careful surveillance and early surgery. Conversely, patients with less severe mitral regurgitation might be reassured of the good medium term prognosis, and require less frequent follow-up, thereby improving the efficient use of healthcare resources.
Observational studies have shown better outcomes in patients undergoing early surgery for mitral regurgitation, 6, 35 but their limitations are well recognised. A randomised trial comparing early surgery with surgery based on conventional indications is required to demonstrate patient benefit, and our study may provide the basis for such a trial, with quantitative CMR indices providing the appropriate tool for identifying suitable patients.
Limitations
The moderate sample size and relatively small number of events limit the strength of our Accurate assessment of the severity of mitral regurgitation and LV volumes/funct t tio io ion n n is is is c c cru ru ruci ci cial al al in clinical decision making 7 and CMR would already seem well suited for this. The additional abilit it ity y y to to to p p pre re redi d d ct t t t t the h h onset of symptoms or other r r in in indi d d cations for surgery y y ju ju just prior to their o o occu cu currence wou u ul ld ld be e e c c clin in inic ic ical al ally ly ly i i im mp mpor o o ta ta tan nt, an an nd d d migh gh ht id d den en enti ti tify fy fy a sui u u ta ta tabl bl ble e e co oho o ort rt rt f f for or r c c car a a ef ef efu u ul u u urv rv rvei e e llance e e a a and d ea ar a ly y su ur u gery ry ry. Co C nv nv nver r rse e ely y, , , pa pa patien nts s s w w wi i ith h h le e ess ss ss s s sev ev ve er ere e mi mi itr ral r r reg eg egurgi gi ita ta tat t tion n m m migh h ht be be be r r rea ea eass ss ssur r ured ed ed o o of f f th th the e e go go good od od m m med ed ediu i ium m m te te term rm rm p p pro ro rogn gn gnos os osis is is, an an and d d re re requuir ir ire e e le le less ss ss f f fre re requuen en ent t t fo fo foll ll llow o ow-up p p, t t the he here re reby b by conclusions, though follow up was for a reasonable period of time (mean 2.5 years, maximum 8 years). Although the study suggests that CMR may be used to identify candidates for early mitral surgery, there is no evidence that operating earlier achieves a clinical benefit. This would require a clinical trial, which we strongly encourage. In addition, our thresholds for separating groups were derived from a single cohort, without a separate validation cohort to confirm the cut-points or the degree of separation. It is likely therefore that the degree of separation between sub-groups may be lower than in this study, and/or the thresholds for separating groups may vary. A validation cohort would be required to confirm these thresholds. In addition, the use of single cut-points to separate groups may underestimate the degree to which there is an incremental risk with increasing values of the parameters. Although we only identified further separation with multiple thresholds for mitral regurgitant fraction, larger sample sizes and different cohorts may reveal an incremental risk for other parameters.
The lack of blinding to the CMR data in three of the investigating centres may also have biased outcome. However, there are no current CMR criteria/thresholds for recommending surgery, and we attempted to minimise bias where possible and confirmed that there were no significant differences in the association with the progression to surgery between centres.
Nevertheless, remaining bias is possible, particularly given the subjective nature of symptom assessment.
The echocardiographic studies were acquired for clinical purposes, and it is possible that these were not as comprehensive as those performed specifically for a research study might be.
Every effort was made however to ensure the best quality assessment, including blinded reanalysis by the researchers.
This study relies on events over time and it is possible that some subjects assigned to the with increasing values of the parameters. Although we only identified further sep p par ar arat at atio io ion n n wi wi with th th multiple thresholds for mitral regurgitant fraction, larger sample sizes and different cohorts may eve eal al al a a an n n in in incr cr crem m men en ntal risk for other parameters.
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We did not include data on subjects' medication, and it is possible that outcome may have been influenced by this. However, no previous studies have shown a significant effect of any drug on outcome in mitral regurgitation.
Conclusions
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Clinical Perspective
Early surgery has been advocated for asymptomatic patients with severe mitral regurgitation if valve repair is likely, but identifying suitable patients is difficult as many would remain asymptomatic for years without surgery. A greater ability to identify those that might benefit from early surgery would be highly advantageous. We assessed the ability of cardiovascular magnetic resonance (CMR) quantification of mitral regurgitation to predict the development of symptoms or other conventional indications for surgery in the near future, as these patients might represent a suitable group for early surgery. 109 asymptomatic patients with echocardiographic moderate or severe MR had baseline CMR scans and were followed for up to 8 years. CMR quantification showed a strong ability to predict patients who progressed to require surgery: 91% of subjects with regurgitant volume 55ml survived to 5 years without surgery compared to only 21% with regurgitant volume >55ml (p<0.0001); and similar separation was observed for regurgitant fraction below and above 40%. CMR-derived end-diastolic volumes or function did not add to the discriminatory power of regurgitant fraction/volume alone but are important for overall patient assessment. CMR may thus be able to identify patients likely to develop symptoms or other conventional indications for surgery in the near future, who would be an appropriate target group for early surgery, to avoid the potential reduced prognosis by the time symptoms occur. The clinical benefits of early surgery require confirmation in a clinical trial however.
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